Pan Drugs informs about closure of trading window

09 Feb 2017 Evaluate

Pan Drugs has informed that a meeting of the Board of Directors of the Company is scheduled to be held on February 13, 2017, to consider and approve the Unaudited Quarterly Financial Results for the quarter (Q3) and nine months ended December 31, 2016. Further pursuant to the provisions of the SEBI (Prohibition of Insider Trading Regulations), 1992 and the Code for Prevention of Insider Trading (Code) of the Company, the trading window for dealing in the Securities of the Company shall remain close for Directors, Officers and Designated Persons, from February 04, 2017 up to 48 Hours after announcement of financial results.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.